Skip to content
Agentic OS
Menu

Intelligence / Healthtech / Device Recalls / Illumina, INC.

QualityClass II recall11 Nov 2026

Illumina, INC.

11 Nov 2026: Class II recall · MiSeq Dx Instrument REF: DX-410-1001 / 15036706, FOR IN VITRO DIAGNOSTIC USE. Recorded in the openFDA device enforcement reports.

View the source record

Reported
11 Nov 2026
Recall Class
Class II
Product
MiSeq Dx Instrument REF: DX-410-1001 / 15036706, FOR IN VITRO DIAGNOSTIC USE
Reason
(Retrospectively reported) Cybersecurity vulnerability identified in communication protocol between the customer-provided infrastructure (network storage, servers, or computers) and in vitro diagnostic devices which may result in compromise
Country
United States
Status
Ongoing
Reference
Z-0321-2027
Location
San Diego, CA
What this signal means

A recall puts quality, regulatory, field service and communications under pressure at once.

  1. Class II leads with 660 of 741, then Class I (68).
  2. 235 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Illumina, INC.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this quality signal, for your approval.

Start free

Across AOS Research

Other records for Illumina, INC. in our registers.

More in Class II

Device Recalls

See all

Source: openFDA device enforcement reports, data to 18 Nov 2026. Device recalls classified by FDA, by report date. Class I is the most serious. AOS shows what the public record says; it does not verify or endorse the company.